홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → N-(4-Fluorobenzyl)-3-hydroxy-10-(((4-((4-(4-morpholinylsulfonyl)phenyl)sulfonyl)-1-piperazinyl)(oxo)acetyl)amino)-4-oxo-4,6,7,8,9,10-hexahydro-7,10-ethanopyrimido[1,2-a]azepine-2-carboxamide

HRID 1093136
인쇄

반응식

HRID 1093136 반응식
[F:1][C:2]1[CH:37]=[CH:36][C:5]([CH2:6][NH:7][C:8]([C:10]2[N:11]=[C:12]3[C:18]4([NH:21][C:22](=[O:31])[C:23](=[O:30])[N:24]5[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]5)[CH2:19][CH2:20][CH:15]([CH2:16][CH2:17]4)[CH2:14][N:13]3[C:32](=[O:35])[C:33]=2[OH:34])=[O:9])=[CH:4][CH:3]=1.C(N(C(C)C)CC)(C)C.[O:47]1[CH2:52][CH2:51][N:50]([S:53]([C:56]2[CH:61]=[CH:60][C:59]([S:62](Cl)(=[O:64])=[O:63])=[CH:58][CH:57]=2)(=[O:55])=[O:54])[CH2:49][CH2:48]1.[O-]CC.[Na+].Cl>ClCCl.O>[F:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][NH:7][C:8]([C:10]2[N:11]=[C:12]3[C:18]4([NH:21][C:22](=[O:31])[C:23]([N:24]5[CH2:25][CH2:26][N:27]([S:62]([C:59]6[CH:60]=[CH:61][C:56]([S:53]([N:50]7[CH2:51][CH2:52][O:47][CH2:48][CH2:49]7)(=[O:55])=[O:54])=[CH:57][CH:58]=6)(=[O:63])=[O:64])[CH2:28][CH2:29]5)=[O:30])[CH2:19][CH2:20][CH:15]([CH2:16][CH2:17]4)[CH2:14][N:13]3[C:32](=[O:35])[C:33]=2[OH:34])=[O:9])=[CH:36][CH:37]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 313Hydrochloric AcidHCID 81531DiisopropylethylamineHCID 2723922Sodium ethoxideHCID 27797904-(Morpholine-4-sulfonyl)benzene-1-sulfonyl chlorideHCID 57904939N-(4-Fluorobenzyl)-3-hydroxy-4-oxo-10-((oxo(1-piperazinyl)acetyl)amino)-4,6,7,8,9,10-hexahydro-7,10-ethanopyrimido[1,2-a]azepine-2-carboxamide

생성물 1

HCID 57905314
N-(4-Fluorobenzyl)-3-hydroxy-10-(((4-((4-(4-morpholinylsulfonyl)phenyl)sulfonyl)-1-piperazinyl)(oxo)acetyl)amino)-4-oxo-4,6,7,8,9,10-hexahydro-7,10-ethanopyrimido[1,2-a]azepine-2-carboxamide
수율 7%

시약·촉매·용매 2

HCID 962Water용매HCID 6344Dichloromethane용매2회

실험 절차

To a mixture N-(4-fluorobenzyl)-3-hydroxy-4-oxo-10-((oxo(1-piperazinyl)acetyl)amino)-4,6,7,8,9,10-hexahydro-7,10-ethanopyrimido[1,2-a]azepine-2-carboxamide (25 mg, 0.040 mmol) in dichloromethane (1 mL) was added diisopropyl ethylamine (0.028 mL, 0.160 mmol) followed by 4-(morpholinosulfonyl)benzene-1-sulfonyl chloride (13.00 mg, 0.040 mmol) and the resulting solution stirred at room temperature for 24 h. The mixture was treated with sodium ethoxide (0.015 mL, 0.040 mmol) and stirred at room temperature for 1 h. The reaction was diluted with water and dichloromethane. The aqueous phase was acidified with 1N HCl and the product extracted into the organic phase. The organic phase was concentrated and the residue was triturated with methanol. The white solids were collected by filtration to give the title compound (2.2 mg, 7% yield). (M+H) calcd for C35H41FN7O10S2: 802.23; found: 802.84. 1H NMR (400 MHz, CDCl3) δ: 11.94 (1 H, s), 8.70 (1 H, s), 8.17 (1H, t, J=6.02 Hz), 7.91 (4 H, s), 7.31 (2 H, dd, J=8.41, 5.40 Hz), 6.96 (2 H, t, J=8.66 Hz), 4.51 (2 H, d, J=6.02 Hz), 4.04-4.22 (4 H, m), 3.67-3.80 (4 H, m), 3.44-3.65 (2 H, m), 2.88-3.20 (8 H, m), 2.50-2.67 (2 H, m), 2.46 (1 H, brs), 1.79-2.06 (4 H, m), 1.58-1.77 (2 H, m).

후처리

  1. stirringstirred at room temperature for 1 h
  2. extractionthe product extracted into the organic phase
  3. concentrationThe organic phase was concentrated
  4. customthe residue was triturated with methanol
  5. filtrationThe white solids were collected by filtration

출처 및 근거

ORD 기록
ord-14c2ba15ec1d46ebb4f04e36653ead09
출처 데이터셋
uspto-grants-2012_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08129398B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트